Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Hornykiewicz
O
O
Institute of Biochemical Pharmacology, University of Vienna, Austria.
D003342:Corpus Striatum / Q000503:physiopathology*; D004298:Dopamine / Q000502:physiology*; D005973:Glutamine / Q000502:physiology; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology; D007926:Lesch-Nyhan Syndrome / Q000503:physiopathology; D008305:Malignant Hyperthermia / Q000503:physiopathology; D009474:Neurons / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology*; D011954:Receptors, Dopamine / Q000502:physiology*; D017470:Receptors, Glutamate / Q000502:physiology; D013378:Substantia Nigra / Q000503:physiopathology*
D011954:Receptors, Dopamine; D017470:Receptors, Glutamate; D005973:Glutamine; D004298:Dopamine